Isifo sesibindi esinamafutha sikhona ku-spectrum kusuka esibindini esinamafutha alula (NAFLD) kuya esibindini esinamafutha avuthayo (NASH).E-United States, ukusabalala kwezifo zesibindi esinamafutha kusuka kumaphesenti angu-10-46%, kanti izifundo ezisekelwe esibindini zibika ukwanda kwe-NASH ka-1-17%.Ukubuyekezwa okuhlelekile kusikisela ukusabalala kwe-NAFLD kubantu abadala cishe ku-25-33%, kuyilapho ukusabalala kwe-NASH kungu-2-5%.Ngokuvamile, iziguli ezinezilonda ezithuthuke kakhulu ze-NASH zisengozini yokuthuthukisa izicubu ezibomvu esibindini (fibrosis) ezingadlulela ku-cirrhosis nesifo sesibindi sokuphela.Ngakho-ke, ukuqapha ukusebenza kwesibindi sekuyingxenye ebalulekile yokuphila kwansuku zonke.
I-Konsung ephathekayo ye-biochemical analyzer isebenzisa indlela yokubona, eqinisekisa ukunemba kwezinga lomtholampilo (CV≤5%).Idinga kuphela u-45μL wegazi lomunwe, inani le-ALB, i-ALT ne-AST lizohlolwa phakathi namaminithi angu-3 futhi imiphumela yokuhlolwa ibonakale kusikrini sokuthinta esingu-4.3.Ukugcinwa kwemiphumela yokuhlolwa engu-3000 kunikeza lula kakhulu ukuqapha ukusebenza kwesibindi ekuphileni kwansuku zonke.
Konsung medical, gxila eminye imininingwane yakho#ukunakekela impilo.
Isikhathi sokuthumela: Mar-24-2022